On August 29, 2019 Johnson & Johnson (NYSE: JNJ) reported that it will participate in the 2019 Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10th, at The Grand Hyatt Hotel in New York (Press release, Johnson & Johnson, AUG 29, 2019, View Source;johnson-to-participate-in-the-2019-morgan-stanley-17th-annual-global-healthcare-conference-300909436.html [SID1234539127]). Peter F. Lebowitz, M.D., Ph.D. Global Therapeutic Area Head, Oncology and Scott White, Company Group Chairman North America Pharmaceuticals will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast replay will be available approximately two hours after the live webcast.